Related Experiment Video
Updated: May 23, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
Published on: September 27, 2024
Aspirin-exacerbated respiratory disease: burden of disease
Jinny E Chang1, Andrew White, Ronald A Simon
1Scripps Clinic, La Jolla, California, USA. Chang.Jinny@scrippshealth.org
Abstract:
Aspirin-exacerbated respiratory disease (AERD) is characterized by adult onset of asthma, chronic rhinosinusitis (CRS), nasal polyposis, and aspirin sensitivity. In this syndrome, each disease component has deleterious effects on the patient's health and quality of life. Latest figures from the Centers for Disease Control indicate 8.2% of the U.S. population has asthma and among adult asthmatic patients, up to 9% have AERD. Approximately 13% of the population suffers from CRS and 15% of patients with CRS with nasal polyposis have AERD. A review of the impact that each component of AERD has on patients will delineate the considerable burden of AERD, especially when considering the cumulative effects of the tetrad.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma III: Clinical Manifestations
Asthma-I: Introduction
Other Pulmonary Disorders
Asthma I: Introduction
